Herzlich willkommen, Prof. Matthias Tschöp! Der international anerkannte Arzt und Medizinforscher ist der neue Präsident der Ludwig-Maximilians-Universität München (LMU). ✨

Das Ziel: ein universeller Grippeimpfstoff - mach mit bei unserer Influenza-Impfstudie. Wir suchen Teilnehmende ab 18 Jahren. Aufwandsentschädigung von bis zu ca. 500 €. www.lmu-klinikum.de/tropeninstit... #Grippe #Influenza #Impfung #Forschung

#Tuberculosis poses a serious threat to people with weakened immune systems. However, standard testing is not sufficient for reliable TB diagnosis or prediction, as a high-profile study involving more than 2,600 patients from eleven European countries revealed @fzborstel.bsky.social @uni-saarland.de

📢 Great news for scientists interested in presenting their work on our #DZIFPEGJointMeeting in Bonn next year: you can submit your #abstracts until August 31! 👉 Don’t miss out and submit your abstract here: : dzif-peg-annual-meeting.de/programme-ab...

Our Teaching & Training Unit invites you to the next Humanitarian Symposium Munich on “Humanitarian aid in the light of the current geopolitical situation” which will take place in Munich on February 14, 2026. Further details & contact to the organizing team: www.cih.lmu.de/events/2026/...

📢 #CallforApplications: Are you conducting translational infection research in Germany? The DZIF Academy is now accepting applications for the 2025 DZIF Prize for Translational Infection Research! 👉 Apply now and learn more about the award: www.dzif.de/en/apply-now...

🔬 Don’t miss your chance to present at the DZIF / PEG Joint Meeting 2026 in Bonn! 🗓 Abstract deadline: Aug 15, 2025 | Poster: Sept 30, 2025 🎟 Submit, register & book now: 👉 dzif-peg-annual-meeting.de #InfectionResearch #DZIF #PEG2026

Ein internationales Team – unter Beteiligung von Prof. Marcus Altfeld (LIV) – ruft in einem The Lancet HIV-Kommentar zu mehr Investitionen in die #HIV-Heilungsforschung auf. Mehr Infos: www.leibniz-liv.de/aktuelles/ne... @dzif.bsky.social @leibniz-gemeinschaft.de Bild ©Adobe Stock, MingQi

💡 Sie suchen fundierte Informationen zu #HepatitisB & #HepatitisD? Die Kampagne „Aufklärung zu #HDV & #HBV“ von #TherVacB & #DSOLVE erklärt Co-Infektion, Diagnose und Therapie in Videos mit Expertinnen & Patientenperspektiven⚕️ 📺 Zur Videoreihe: tinyurl.com/HepatitisBDW... #WHT2025 #HepSky

Fighting #HepatitisB #TherVacB, a new therapeutic vaccine for chronic hepatitis B from #HelmholtzMunich, starts phase 1b/2a trial in patients. It aims to boost the immune system to eliminate the virus. 👉 t1p.de/qcncm @lmu-klinikum.bsky.social @tum.de @ulrike-protzer.bsky.social

🧪 #TherVacB, a novel therapeutic vaccine for chronic hepatitis B, has entered its first clinical trial in patients. This major milestone has been reached by DZIF scientists at @www.helmholtz-munich.de, @tum.de and @lmumuenchen.bsky.social. 🏥 👉 www.dzif.de/en/therapeut... 👉 @thervacb-eu.bsky.social

I was taking 23 pills every day for 10 months.” A TB survivor shared this at ERA4TB’s MDR-TB dialogue. Behind every protocol is a person. That’s why we say “people affected by TB” or “TB survivors”. Language shifts power, from object to partner. Research must listen and build with communities.

On behalf of the TB Sequel consortium, PostTB Care & The Union, we’re delighted to invite you to the next Community Call on "Post-TB lung disease in children & adolescents, insights from an African perspective" by Prof. Lisa Obimbo Wednesday, 10 September 2025 14:00–15:00 SAST #Tuberculosis #PTLD

🏆 #Honored: Six doctoral & two post-doctoral #LMU researchers receive sponsorship awards from #MUG 🎓 This year, the topics range from innovative methods for the early detection of cancer to the question of whether new risks posed by artificial intelligence (AI) require new legal concepts.

Der #Klimawandel begünstigt die Ausbreitung von #Tropenkrankheiten – auch in Deutschland. Im Fokus: das #Chikungunya-Virus. Wie groß das Risiko derzeit ist, dass sich das Virus in Europa etabliert, beleuchtet der #Deutschlandfunk. www.deutschlandfunk.de/chikungunya-...

On behalf of our Teaching & Training Unit and the Center for International Health, we are thrilled to share that our PhD student, Aikins Ablorde, successfully completed his PhD. Read more about the PhD Graduation Ceremony: bit.ly/46TkKlY Images (c) LMU Klinikum/N.Krakani @lmu-klinikum.bsky.social

Kürzlich hatten wir in unserer Ambulanz einen Dreh für die @brkommunikation.bsky.social Sendung „Gesundheit“ zum Thema Hepatitis im Zusammenhang mit Reiseimpfungen. 🎥 Im Beitrag erfahrt ihr mehr & auch zum @thervacb-eu.bsky.social Projekt. www.ardmediathek.de/video/Y3JpZD... (ab Min. 12:40/14.34)

🦟 Die STIKO empfiehlt erstmals die #Impfung gegen #Chikungunya – für bestimmte #Reisende und Berufsgruppen mit Kontakt zu Chikungunya-Viren. 🩹 Empfohlen werden zwei Impfstoffe (Vimkunya und Ixchiq), jeweils als Einmaldosis. Mehr zur Empfehlung im aktuellen #EpidBull: 🔗 www.rki.de/DE/Aktuelles...

Unsere Ambulanzleiterin PD Dr. Camilla Rothe ist Tropenmedizinerin und Mitglied im ADAC Ärztekollegium. Im Gespräch mit der ADAC Redaktion erklärt sie, warum der Klimawandel neue Infektionsrisiken mit sich bringt und wie Sie sich schützen können: www.adac.de/news/camilla... #Klimawandel #Vorsorge

Lilian Tina Minja & @norbertheinrich.bsky.social discuss two recent trials (SUDOCU & DECODE) published in @thelancetinfdis.bsky.social. The studies are part of the PanACEA Consortium, a European-African partnership advancing TB research 🎧 thelancetinfectiousdiseases.buzzsprout.com/1740310/epis...

Sichere Alternativen zu toxischem Tuberkulose-Medikament Zwei internationale klinische Studien unter der Leitung von PD Dr. Norbert Heinrich vom Tropeninstitut des LMU Klinikums München und internationalen Partnerinstitutionen belegen die Siche... weiterlesen

Just published in @thelancetinfdis.bsky.social: Research of Institute of Infectious Diseases and Tropical Medicine at @lmu-klinikum.bsky.social and #PanACEA consortium partners shows two novel antibiotics could spare patients from severe side effects Read more: www.lmu-klinikum.de/tropical-ins...

🎧 Neue Folgen des Infektiopod sind da! In #94–96 geht's um S. aureus-Bakteriämie, Varizella-Zoster & C. difficile. Medizin verständlich erklärt von Dr. Koch, Dr. Hennigs & Dr. Terhalle – jetzt reinhören! Unterstützt vom @dzif.bsky.social 🔗 infektiopod.de #Infektiopod #Infektiologie

@gardp.bsky.social REVIVE Webinar on "Repurposing Drugs to Address the Crisis of AMR": exploring how existing drugs are being repurposed to combat AMR. 🗓️ July 22, 2025 🕤 09.30am - 11am CEST It includes an interactive Q&A session. Registration ➡️ register.gotowebinar.com/register/200...

💉 #HelmholtzMunich joins the European Vaccines Hub (EVH) to boost #PandemicPreparedness. 🔬 The EVH unites EU partners – covering the full pipeline from #vaccine discovery to manufacturing. 👉 t1p.de/vdi16 @ec.europa.eu @evhproject.bsky.social

🚨 Big move for medical research in Germany: #LMU, @tum.de , their university hospitals & @www.helmholtz-munich.de launch the M1 Munich Medicine Alliance to boost innovation, research & healthcare in Munich. 🔬🚀 🔗 Read more: www.lmu.de/en/newsroom/... #M1 #MunichMedicineAlliance

Some impressions from yesterday’s panel discussion at the #BayOConnect2025 on “Dealing with Infectious Diseases – Strategies to Prevent Future Outbreaks,” with our Director Prof. Michael Hoelscher among the speakers. www.bayoconnect.org/bayoconnect-... Photo credit (c) Bert Willer/birdyfoto

Hot off the press! We’re thrilled to launch the first issue of the 𝘚𝘖𝘍𝘈𝘙 𝘕𝘦𝘸𝘴𝘭𝘦𝘵𝘵𝘦𝘳 Meet our PhD fellows, explore regional updates, and celebrate big wins across 🇿🇼🇿🇲🇲🇿 Read more: sofarafrica.org/post/sofar-n... @lshtm.bsky.social @tropeninstitut.bsky.social @zambartresearch.bsky.social

LMU opens ICON, a new research center uniting interdisciplinary expertise to accelerate innovative cardiovascular diagnostics and therapies from bench to bedside. #LMU #LMUKlinikum #ICON www.lmu.de/en/newsroom/...

🔥 Now online: “LMU Research and Innovation” - the new digital #researchmagazine from #LMUMunich! Focus of the first issue: HEAT 🌍 From climate change to conflicts - interdisciplinary insights into current research. ➡️ Read it now: www.lmu.de/en/about-lmu... #LMUResearchAndInnovation #Heat

Many congrats and a big applause to our affiliated researcher @kkranzer.bsky.social who received the EDCTP Women Scientific Leadership Prize at the EDCTP Forum in Kigali, Rwanda (June 15-20, 2025), and well as to all the other awardees! 🏆 🎊 Photo: Global Health EDCTP3

Happy to announce the Lancet Infect. Dis review on filariasis, by the Lancet Commission on Vector borne helminthiases, of which I have the honor to be a member. @dzif.bsky.social @dzifbonn-koeln.bsky.social @unibonn.bsky.social @tropeninstitut.bsky.social authors.elsevier.com/c/1lHca5E-Uo...

Don't miss the chance to attend the UNITE4TB webinar! Join to learn on revolutionizing TB diagnosis: moving beyond sputum with innovative, noninvasive tools that improve detection, guide care and drive change.   🗓️ 26 June 2025 ⏰ 13:00-14:00 CEST   🔗 Register now: bit.ly/3FG8sm7

Die EU droht bei der Bekämpfung von #Infektionskrankheiten ins Hintertreffen zu geraten. Trotz globaler Verpflichtungen bleibt sie deutlich hinter den formulierten Zielen der UN für 2030 zurück. @apothekenumschau.bsky.social erläutert: www.apotheken-umschau.de/podcast/epis...

In Penzberg entsteht ein modernes Zentrum für Immunologie, Infektions- und Pandemieforschung. Wesentlich beteiligt: Forschende von LMU und LMU Klinikum. Alle Infos gibt’s hier: www.lmu-klinikum.de/aktuelles/ne...

📍 Penzberg: 🏗️ Construction of the Fraunhofer Institute for Translational Medicine and Pharmacology ITMP begins with today's ground-breaking ceremony. A modern institute building for infection, immune and pandemic research - with strong involvement from LMU Munich & @lmu-klinikum.bsky.social 👏

Prof Katharina Kranzer is the new Chair of the committee responsible for developing the Union Conference programme. As part of #IWD25 we learn more about Katharina, what inspired her to become a microbiologist and her new role at The Union – in her own words: theunion.org/news/IWD25-P...

Always fab to turn around and see the glorious Katharina Kranzer on TV!

Only 2 spots left! Don't miss your chance to join the Diploma in Tropical Medicine and International Health (DTMIH) at @lmumuenchen.bsky.social – hosted by the Center for International Health (CIH). More info & apply now at: www.cih.lmu.de/education/sh...

New insights into immune cell activation by the yellow fever vaccine help explain its strong effects — and could support the development of new vaccines. #LMUMunich #immunology www.lmu.de/en/newsroom/...

Historic decision at #WHA78: Member States of WHO today formally adopted by consensus the world's first #PandemicAgreement to make the world more equitable and safer from future pandemics. 🔗 bit.ly/43p0DsH

It's official: the #PandemicAccord is officially adopted by the World Health Assembly! My warmest congratulations to @who.int Member States for their commitment to keeping their people and the world safer. What a moment in global health history. Together!

The SOFAR Project is now live on the EU CORDIS platform! Proud to be part of this @EDCTP3 -funded @horizoneu.bsky.social initiative strengthening infectious disease research in 🇿🇼🇿🇲🇲🇿 cordis.europa.eu/project/id/1... @zambartresearch.bsky.social @tropeninstitut.bsky.social @lshtm.bsky.social

Yesterday was a full day of science, partnership, and vision at the UNITE4TB Annual Meeting Science Day! From academic breakthroughs to shaping future TB care expectations with regulators and communities — it showcased the strength of the collective effort in UNITE4TB. (c) UNITE4TB

From cross-consortium Work Package updates to strategic operational discussions: Collaboration was the theme of the first day of the 2025 UNITE4TB Annual Meeting in London - as captured in this group photo of consortium members. (c) UNITE4TB

We're excited to be part of the 2025 UNITE4TB Annual Meeting which kicked off in London today with updates from all 12 Work Packages. Also on today's agenda: an assessment of the PARADIGM4TB trial and insights from the UNITE4TB Advisory Boards. (c) shared from the UNITE4TB LinkedIn Account

Join a community of experts exchanging knowledge on the latest developments & innovations in TB - all focused on the African continent. The 2nd Conference on Innovations in Tuberculosis, will take place on 12 May 2025 in Windhoek, Namibia. Learn more at: academicmedicaleducation.com/meeting/2nd-...

11 African nations account for 2/3 of the global #malaria burden: Burkina Faso Cameroon Democratic Republic of the Congo Ghana Mali Mozambique Niger Nigeria Sudan Tanzania Uganda In 2024, Ministries of Health in these countries signed a declaration pledging to reduce malaria deaths.

It’s #WorldMalariaDay The good news: 2.2 billion #malaria cases and 12.7 million deaths have been averted since 2000. The bad news: after years of steady declines, progress has stalled. bit.ly/MalariaDay2025

📣 Register now: 2nd Long COVID Symposium of the German Centers for Health Research (DZG) 📆 9 May 2025, 9:00 to 17:00 📍 Frankfurt am Main, Senckenberg Museum 🔗 Sign up here: deutschezentren.de/2nd-long-cov... Participation is open to all interested researchers.